Why AstraZeneca Stock Is Sliding Today

The British drugmaker's Q2 results were good, but seemingly not good enough for many investors.Shares of AstraZeneca (AZN -2.70%) were sliding 3.2% lower as of 10:57 a.m. ET on Thursday. The decline came after the British drugmaker announced its second-quarter results.AstraZeneca reported total revenue in Q2 of $12.9 billion, up 13% year over year. This result topped the average analysts' revenue estimate of $12.6 billion.The company posted earnings per share (EPS) of $1.24, a 6% year-over-year increase. It ...